Ryuji Mizumoto
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Surgery top 2%
- Cholangiocarcinoma and Gallbladder Cancer Studies 21
- Pancreatitis Pathology and Treatment 13
- Pediatric Hepatobiliary Diseases and Treatments 11
- Organ Transplantation Techniques and Outcomes 8
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 25
-
- Gallbladder and Bile Duct Disorders 8
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Yoshifumi KawaradaYoshifumi OguraMasami TabataShinsuke MatsudaHideaki SuzukiTsukasa KUSUDAHideki SuzukiTakashi Noguchi
- Cited by
- HepatologySurgeryOncology
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Ryuji Mizumoto
91 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 92
- Hepatology 704
- Surgery 1.4k
- Oncology 825
- Pulmonary and Respiratory Medicine 751
- Epidemiology 438
Countries citing papers authored by Ryuji Mizumoto
This map shows the geographic impact of Ryuji Mizumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Mizumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Mizumoto more than expected).
Fields of papers citing papers by Ryuji Mizumoto
This network shows the impact of papers produced by Ryuji Mizumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Mizumoto. The network helps show where Ryuji Mizumoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryuji Mizumoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 17 | |
| 2 | 1999 | 18 | |
| 3 | 1999 | 23 | |
| 4 | 1998 | 10 | |
| 5 | 1997 | 14 | |
| 6 | 1995 | 7 | |
| 7 | 1992 | 6 | |
| 8 | 1991 | 12 | |
| 9 | 1991 | 18 | |
| 10 | 1991 | 9 | |
| 11 | 1990 | 1 | |
| 12 | 1990 | 1 | |
| 13 | 1990 | 2 | |
| 14 | 1988 | 1 | |
| 15 | 1988 | 1 | |
| 16 | 1986 | 1 | |
| 17 | 1986 | 7 | |
| 18 | 1985 | 1 | |
| 19 | 1984 | 3 | |
| 20 | 1981 | 2 |
About Ryuji Mizumoto
Ryuji Mizumoto is a scholar working on Hepatology, Surgery and Oncology, having authored 96 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Pancreatitis Pathology and Treatment (13 papers), Pediatric Hepatobiliary Diseases and Treatments (11 papers), Organ Transplantation Techniques and Outcomes (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Gallbladder and Bile Duct Disorders (8 papers). The work is most often cited by research in Hepatology (704 citations), Surgery (1.4k citations) and Oncology (825 citations). Ryuji Mizumoto has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Yoshifumi Kawarada, Yoshifumi Ogura, Masami Tabata, Shinsuke Matsuda, Hideaki Suzuki, Tsukasa KUSUDA, Hideki Suzuki, Takashi Noguchi, Shuji Isaji and Takayoshi Tobe. Their work appears in journals such as Cancer, Carcinogenesis and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.